PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Alkem Laboratories Limited (ALKEM.NS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISININE540L01014
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap₹572.69B
EPS₹131.72
PE Ratio36.36
PEG Ratio-1,057.29
Revenue (TTM)₹126.34B
Gross Profit (TTM)₹65.79B
EBITDA (TTM)₹21.93B
Year Range₹3,157.64 - ₹5,520.00
Target Price₹4,880.67

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ALKEM.NS

Alkem Laboratories Limited

Performance

Performance Chart

The chart shows the growth of an initial investment of ₹10,000 in Alkem Laboratories Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


150.00%200.00%250.00%300.00%OctoberNovemberDecember2024FebruaryMarch
286.31%
221.38%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

S&P 500

Returns By Period

Alkem Laboratories Limited had a return of -4.38% year-to-date (YTD) and 51.10% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-4.38%10.16%
1 month-2.02%3.47%
6 months41.14%22.20%
1 year51.10%30.45%
5 years (annualized)25.00%13.16%
10 years (annualized)N/A10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-3.97%3.31%
2023-8.22%-1.01%3.22%26.91%10.14%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Alkem Laboratories Limited (ALKEM.NS) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ALKEM.NS
Alkem Laboratories Limited
2.41
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Alkem Laboratories Limited Sharpe ratio is 2.41. A Sharpe ratio higher than 2.0 is considered very good.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00OctoberNovemberDecember2024FebruaryMarch
2.41
3.02
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Dividends

Dividend History

Alkem Laboratories Limited granted a 0.91% dividend yield in the last twelve months. The annual payout for that period amounted to ₹45.00 per share.


PeriodTTM20232022202120202019201820172016
Dividend₹45.00₹35.00₹34.00₹30.00₹25.00₹16.00₹13.00₹9.00₹15.70

Dividend yield

0.91%0.67%1.13%0.83%0.85%0.79%0.67%0.41%0.96%

Monthly Dividends

The table displays the monthly dividend distributions for Alkem Laboratories Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024₹0.00₹35.00
2023₹0.00₹25.00₹0.00₹0.00₹0.00₹0.00₹0.00₹10.00₹0.00₹0.00₹0.00₹0.00
2022₹0.00₹30.00₹0.00₹0.00₹0.00₹0.00₹0.00₹4.00₹0.00₹0.00₹0.00₹0.00
2021₹0.00₹25.00₹0.00₹0.00₹0.00₹0.00₹0.00₹5.00₹0.00₹0.00₹0.00₹0.00
2020₹0.00₹22.00₹0.00₹0.00₹0.00₹0.00₹0.00₹3.00₹0.00₹0.00₹0.00₹0.00
2019₹0.00₹8.00₹0.00₹0.00₹0.00₹0.00₹0.00₹8.00₹0.00₹0.00₹0.00₹0.00
2018₹0.00₹6.00₹0.00₹0.00₹0.00₹0.00₹0.00₹7.00₹0.00₹0.00₹0.00₹0.00
2017₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹9.00₹0.00₹0.00₹0.00₹0.00
2016₹9.70₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹0.00₹6.00₹0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%0.9%
Alkem Laboratories Limited has a dividend yield of 0.91%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%44.3%
Alkem Laboratories Limited has a payout ratio of 44.27%, which is quite average when compared to the overall market. This suggests that Alkem Laboratories Limited strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-20.00%-15.00%-10.00%-5.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-9.68%
0
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alkem Laboratories Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alkem Laboratories Limited was 27.40%, occurring on Jun 28, 2019. Recovery took 132 trading sessions.

The current Alkem Laboratories Limited drawdown is 9.68%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-27.4%Jan 11, 2018358Jun 28, 2019132Jan 13, 2020490
-26.86%Sep 27, 2021158May 17, 2022296Jul 25, 2023454
-23.77%Jan 6, 201686May 13, 201649Jul 22, 2016135
-22.86%Mar 28, 201795Aug 11, 201795Dec 29, 2017190
-18.53%Apr 28, 202022May 29, 202046Aug 3, 202068

Volatility

Volatility Chart

The current Alkem Laboratories Limited volatility is 7.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%OctoberNovemberDecember2024FebruaryMarch
7.46%
2.88%
ALKEM.NS (Alkem Laboratories Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alkem Laboratories Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items